American Society of Gene & Cell Therapy (ASGCT) 2025 Annual Meeting

Date: 13-17 May 2025
Location: Ernest N. Morial Convention Center, New Orleans

Event Website

The American Society of Gene & Cell Therapy (ASGCT) Annual Meeting is one of the leading global events for the latest advances in gene and cell therapy research, development, and clinical translation. It brings together scientists, clinicians, biotech leaders and regulatory experts to shape the future of CGTs.

Representing eXmoor Pharma at this year’s conference will be:

• David Vincent, Head of Development
• Carol Elvira, Business Development Manager

We’ll be presenting two scientific posters at the meeting, showcasing key insights from our process development work in viral vector and cell therapy technologies. These presentations highlight our commitment to delivering robust, scalable, and regulatory-ready solutions that accelerate clinical and commercial success.

We’re keen to connect with therapy developers, academic innovators, and biotech teams navigating the challenges of CGT development and manufacture. Whether you need early-stage strategy, process development, or GMP manufacturing, our integrated consultancy and CDMO services are built to support your full journey from lab bench to commercialisation.

Attending ASGCT 2025?

Connect with David or Carol in New Orleans to explore how we can help advance your cell or gene therapy programme.